Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $293.93 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $250.00 | 2 | $0 (2018) |
| PORTOLA PHARMACEUTICALS, INC. | $16.58 | 1 | $0 (2019) |
| Allergan Inc. | $15.48 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $11.87 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $32.06 | 2 | PORTOLA PHARMACEUTICALS, INC. ($16.58) |
| 2018 | $261.87 | 3 | AstraZeneca Pharmaceuticals LP ($250.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/16/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 11/28/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.87 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 100 | 102 | $134,116 | $14,006 |
| 2022 | 4 | 249 | 251 | $316,332 | $36,725 |
| 2021 | 4 | 461 | 493 | $591,909 | $74,990 |
| 2020 | 4 | 390 | 411 | $481,771 | $63,526 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 83 | 85 | $118,017 | $12,513 | 10.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 17 | 17 | $16,099 | $1,493 | 9.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 172 | 174 | $230,010 | $26,926 | 11.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 28 | 28 | $47,964 | $5,346 | 11.1% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 33 | 33 | $29,766 | $3,439 | 11.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 16 | 16 | $8,592 | $1,014 | 11.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 312 | 339 | $426,690 | $54,503 | 12.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 52 | 54 | $88,238 | $10,621 | 12.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 71 | 74 | $63,695 | $8,174 | 12.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 26 | 26 | $13,286 | $1,693 | 12.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 279 | 299 | $358,683 | $47,624 | 13.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 51 | 51 | $79,359 | $10,600 | 13.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 44 | 44 | $35,450 | $4,370 | 12.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 16 | 17 | $8,279 | $931.49 | 11.3% |
About Dr. Keyur Ajbani, MD
Dr. Keyur Ajbani, MD is a Sports Medicine healthcare provider based in Canonsburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750508297.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keyur Ajbani, MD has received a total of $293.93 in payments from pharmaceutical and medical device companies, with $32.06 received in 2019. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($293.93).
As a Medicare-enrolled provider, Ajbani has provided services to 1,200 Medicare beneficiaries, totaling 1,257 services with total Medicare billing of $189,247. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Emergency Medicine
- Location Canonsburg, PA
- Active Since 04/19/2007
- Last Updated 06/12/2008
- Taxonomy Code 207PS0010X
- Entity Type Individual
- NPI Number 1750508297
Products in Payments
- FARXIGA (Drug) $250.00
- ANDEXXA (Biological) $16.58
- AVYCAZ (Drug) $15.48
- ELIQUIS (Drug) $11.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.